Calcium Signaling and Cardiac Arrhythmias.

There has been a significant progress in our understanding of the molecular mechanisms by which calcium (Ca2+) ions mediate various types of cardiac arrhythmias. A growing list of inherited gene defects can cause potentially lethal cardiac arrhythmia syndromes, including catecholaminergic polymorphic ventricular tachycardia, congenital long QT syndrome, and hypertrophic cardiomyopathy. In addition, acquired deficits of multiple Ca2+-handling proteins can contribute to the pathogenesis of arrhythmias in patients with various types of heart disease. In this review article, we will first review the key role of Ca2+ in normal cardiac function-in particular, excitation-contraction coupling and normal electric rhythms. The functional involvement of Ca2+ in distinct arrhythmia mechanisms will be discussed, followed by various inherited arrhythmia syndromes caused by mutations in Ca2+-handling proteins. Finally, we will discuss how changes in the expression of regulation of Ca2+ channels and transporters can cause acquired arrhythmias, and how these mechanisms might be targeted for therapeutic purposes.

[1]  M. Allessie,et al.  Distinct contractile and molecular differences between two goat models of atrial dysfunction: AV block-induced atrial dilatation and atrial fibrillation. , 2009, Journal of molecular and cellular cardiology.

[2]  M. Ackerman,et al.  Molecular evolution of the junctophilin gene family. , 2009, Physiological genomics.

[3]  R. Haworth,et al.  Abnormal Ca2+ Release, but Normal Ryanodine Receptors, in Canine and Human Heart Failure , 2002, Circulation research.

[4]  G. Tomaselli,et al.  Mechanisms of Disease: ion channel remodeling in the failing ventricle , 2008, Nature Clinical Practice Cardiovascular Medicine.

[5]  Michael J Ackerman,et al.  Nature Genetics Advance Online Publication Genetic Association Study of Qt Interval Highlights Role for Calcium Signaling Pathways in Myocardial Repolarization , 2022 .

[6]  S. Middha,et al.  Homozygous/Compound Heterozygous Triadin Mutations Associated With Autosomal-Recessive Long-QT Syndrome and Pediatric Sudden Cardiac Arrest: Elucidation of the Triadin Knockout Syndrome , 2015, Circulation.

[7]  J. Nerbonne,et al.  Potassium currents in the heart: functional roles in repolarization, arrhythmia and therapeutics , 2017, The Journal of physiology.

[8]  Michael J Ackerman,et al.  A Precision Medicine Approach to the Rescue of Function on Malignant Calmodulinopathic Long-QT Syndrome , 2017, Circulation research.

[9]  F. Mason,et al.  Late INa increases diastolic SR-Ca2+-leak in atrial myocardium by activating PKA and CaMKII , 2015, Cardiovascular research.

[10]  Natalia A. Trayanova,et al.  Mechanisms of arrhythmogenesis related to calcium-driven alternans in a model of human atrial fibrillation , 2016, Scientific Reports.

[11]  Dobromir Dobrev,et al.  Role of RyR2 Phosphorylation in Heart Failure and Arrhythmias: Controversies Around Ryanodine Receptor Phosphorylation in Cardiac Disease , 2014, Circulation research.

[12]  Veniamin Y Sidorov,et al.  Myofilament Ca2+ sensitization causes susceptibility to cardiac arrhythmia in mice. , 2008, The Journal of clinical investigation.

[13]  M. Gollob,et al.  Sudden Death in a Young Man with Catecholaminergic Polymorphic Ventricular Tachycardia and Paroxysmal Atrial Fibrillation , 2008, Journal of cardiovascular electrophysiology.

[14]  Niels Voigt,et al.  Tachycardia-induced silencing of subcellular Ca2+ signaling in atrial myocytes. , 2014, The Journal of clinical investigation.

[15]  Y. Ohya,et al.  Stretch‐Activated Whole‐Cell Currents in Smooth Muscle Cells from Mesenteric Resistance Artery of Guinea‐Pig , 1997, The Journal of physiology.

[16]  Henry M Colecraft,et al.  L-type calcium channel targeting and local signalling in cardiac myocytes. , 2013, Cardiovascular research.

[17]  Alan Garfinkel,et al.  Perspective: a dynamics-based classification of ventricular arrhythmias. , 2015, Journal of molecular and cellular cardiology.

[18]  J. Seidman,et al.  Mutations in the cardiac myosin binding protein–C gene on chromosome 11 cause familial hypertrophic cardiomyopathy , 1995, Nature Genetics.

[19]  M. Ackerman,et al.  Impact of Genotype on the Occurrence of Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy. , 2016, The American journal of cardiology.

[20]  Wei Zhang,et al.  Mice with the R176Q cardiac ryanodine receptor mutation exhibit catecholamine-induced ventricular tachycardia and cardiomyopathy , 2006, Proceedings of the National Academy of Sciences.

[21]  M. Mongillo,et al.  Phosphorylation of the ryanodine receptor mediates the cardiac fight or flight response in mice. , 2010, The Journal of clinical investigation.

[22]  S. Houser,et al.  Hyperphosphorylation of the Cardiac Ryanodine Receptor at Serine 2808 Is Not Involved in Cardiac Dysfunction After Myocardial Infarction , 2012, Circulation research.

[23]  Michael J Ackerman,et al.  Spectrum and prevalence of cardiac ryanodine receptor (RyR2) mutations in a cohort of unrelated patients referred explicitly for long QT syndrome genetic testing. , 2005, Heart rhythm.

[24]  Mark E. Anderson,et al.  Proarrhythmic Defects in Timothy Syndrome Require Calmodulin Kinase II , 2008, Circulation.

[25]  A. Scholten,et al.  SPEG (Striated Muscle Preferentially Expressed Protein Kinase) Is Essential for Cardiac Function by Regulating Junctional Membrane Complex Activity , 2016, Circulation research.

[26]  J. Towbin,et al.  Genetics of arrhythmogenic right ventricular cardiomyopathy: a practical guide for physicians. , 2013, Journal of the American College of Cardiology.

[27]  Donald M. Bers,et al.  Excitation-Contraction Coupling and Cardiac Contractile Force , 2001, Developments in Cardiovascular Medicine.

[28]  Margaret L. Karst,et al.  Cardiac troponin T mutation in familial cardiomyopathy with variable remodeling and restrictive physiology , 2008, Clinical genetics.

[29]  D. Szczesna,et al.  Abnormal Contractile Function in Transgenic Mice Expressing a Familial Hypertrophic Cardiomyopathy-linked Troponin T (I79N) Mutation* , 2001, The Journal of Biological Chemistry.

[30]  I. Rayment,et al.  Mutations in either the essential or regulatory light chains of myosin are associated with a rare myopathy in human heart and skeletal muscle , 1996, Nature Genetics.

[31]  Y. Ishikawa,et al.  Junctophilin type 2 is associated with caveolin-3 and is down-regulated in the hypertrophic and dilated cardiomyopathies. , 2004, Biochemical and biophysical research communications.

[32]  S. Nattel,et al.  Role of Small-Conductance Calcium-Activated Potassium Channels in Atrial Electrophysiology and Fibrillation in the Dog , 2014, Circulation.

[33]  I. V. Van Gelder,et al.  Human SCN5A gene mutations alter cardiac sodium channel kinetics and are associated with the Brugada syndrome. , 1999, Cardiovascular research.

[34]  Michael Christiansen,et al.  Mutations in calmodulin cause ventricular tachycardia and sudden cardiac death. , 2012, American journal of human genetics.

[35]  Heping Cheng,et al.  Catecholaminergic-induced arrhythmias in failing cardiomyocytes associated with human HRCS96A variant overexpression. , 2011, American journal of physiology. Heart and circulatory physiology.

[36]  C. Fahrenbruch,et al.  Incidence, Causes, and Survival Trends From Cardiovascular-Related Sudden Cardiac Arrest in Children and Young Adults 0 to 35 Years of Age: A 30-Year Review , 2012, Circulation.

[37]  J. Gardin,et al.  Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults. , 1995, Circulation.

[38]  Colleen E Clancy,et al.  L-type Ca2+ channel mutations and T-wave alternans: a model study. , 2007, American journal of physiology. Heart and circulatory physiology.

[39]  Y. Oade,et al.  Arrhythmogenic right ventricular cardiomyopathy , 2011, BMJ Case Reports.

[40]  J. Potter,et al.  A Mutation in TNNC1-encoded Cardiac Troponin C, TNNC1-A31S, Predisposes to Hypertrophic Cardiomyopathy and Ventricular Fibrillation* , 2012, The Journal of Biological Chemistry.

[41]  A. Wilde,et al.  Flecainide therapy reduces exercise-induced ventricular arrhythmias in patients with catecholaminergic polymorphic ventricular tachycardia. , 2011, Journal of the American College of Cardiology.

[42]  R. Moss,et al.  Impaired cardiomyocyte relaxation and diastolic function in transgenic mice expressing slow skeletal troponin I in the heart , 1999, The Journal of physiology.

[43]  I. Marty Triadin regulation of the ryanodine receptor complex , 2015, The Journal of physiology.

[44]  R. Vasan,et al.  Age-Specific Trends in Incidence, Mortality, and Comorbidities of Heart Failure in Denmark, 1995 to 2012 , 2017, Circulation.

[45]  E. Haan,et al.  A novel heterozygous mutation in cardiac calsequestrin causes autosomal dominant catecholaminergic polymorphic ventricular tachycardia. , 2016, Heart rhythm.

[46]  Y. Shimoni,et al.  K201 (JTV519) suppresses spontaneous Ca2+ release and [3H]ryanodine binding to RyR2 irrespective of FKBP12.6 association. , 2007, The Biochemical journal.

[47]  Donald M Bers,et al.  Optical Mapping of Sarcoplasmic Reticulum Ca2+ in the Intact Heart: Ryanodine Receptor Refractoriness During Alternans and Fibrillation , 2014, Circulation research.

[48]  Sandor Györke,et al.  The role of calsequestrin, triadin, and junctin in conferring cardiac ryanodine receptor responsiveness to luminal calcium. , 2004, Biophysical journal.

[49]  J. Kere,et al.  Arrhythmic disorder mapped to chromosome 1q42-q43 causes malignant polymorphic ventricular tachycardia in structurally normal hearts. , 1999, Journal of the American College of Cardiology.

[50]  Marielle Alders,et al.  A mutation in CALM1 encoding calmodulin in familial idiopathic ventricular fibrillation in childhood and adolescence. , 2014, Journal of the American College of Cardiology.

[51]  James O. Mudd,et al.  An abnormal Ca2+ response in mutant sarcomere protein–mediated familial hypertrophic cardiomyopathy , 2000 .

[52]  S. Huke,et al.  Ablation of triadin causes loss of cardiac Ca2+ release units, impaired excitation–contraction coupling, and cardiac arrhythmias , 2009, Proceedings of the National Academy of Sciences.

[53]  Joshua T Maxwell,et al.  Refractoriness of sarcoplasmic reticulum Ca2+ release determines Ca2+ alternans in atrial myocytes. , 2012, American journal of physiology. Heart and circulatory physiology.

[54]  Michael Fill,et al.  The Arrhythmogenic Calmodulin p.Phe142Leu Mutation Impairs C-domain Ca2+ Binding but Not Calmodulin-dependent Inhibition of the Cardiac Ryanodine Receptor* , 2016, The Journal of Biological Chemistry.

[55]  X. Wehrens,et al.  Atrial arrhythmogenesis in catecholaminergic polymorphic ventricular tachycardia – is there a mechanistic link between sarcoplasmic reticulum Ca2+ leak and re‐entry? , 2013, Acta physiologica.

[56]  David J. Anderson,et al.  Ventromedial hypothalamic neurons control a defensive emotion state , 2015, eLife.

[57]  K. Campbell,et al.  Purification and characterization of calsequestrin from canine cardiac sarcoplasmic reticulum and identification of the 53,000 dalton glycoprotein. , 1983, The Journal of biological chemistry.

[58]  S. Nattel,et al.  Differential efficacy of L- and T-type calcium channel blockers in preventing tachycardia-induced atrial remodeling in dogs. , 2001, Cardiovascular research.

[59]  F C Stevens,et al.  Calmodulin: an introduction. , 1983, Canadian journal of biochemistry and cell biology = Revue canadienne de biochimie et biologie cellulaire.

[60]  G. Veglia,et al.  Allosteric regulation of SERCA by phosphorylation-mediated conformational shift of phospholamban , 2013, Proceedings of the National Academy of Sciences.

[61]  N. Kaneko,et al.  Inhibition of annexin V-dependent Ca2+ movement in large unilamellar vesicles by K201, a new 1,4-benzothiazepine derivative. , 1997, Biochimica et biophysica acta.

[62]  H. Wellens,et al.  Novel Insights in the Congenital Long QT Syndrome , 2002, Annals of Internal Medicine.

[63]  S. Nattel,et al.  Electrophysiological and molecular mechanisms of paroxysmal atrial fibrillation , 2016, Nature Reviews Cardiology.

[64]  G. Dorn,et al.  The Ser96Ala variant in histidine-rich calcium-binding protein is associated with life-threatening ventricular arrhythmias in idiopathic dilated cardiomyopathy , 2008, European heart journal.

[65]  D TEARE,et al.  ASYMMETRICAL HYPERTROPHY OF THE HEART IN YOUNG ADULTS , 1958, British heart journal.

[66]  D. Tester,et al.  Role of Genetic Testing for Sudden Death Predisposing Heart Conditions in Athletes , 2011 .

[67]  Kerstin Dudas,et al.  Trends in Out-of-Hospital Deaths Due to Coronary Heart Disease in Sweden (1991 to 2006) , 2011, Circulation.

[68]  Dobromir Dobrev,et al.  Calcium‐mediated cellular triggered activity in atrial fibrillation , 2017, The Journal of physiology.

[69]  Simon Capewell,et al.  Explaining the decrease in U.S. deaths from coronary disease, 1980-2000. , 2007, The New England journal of medicine.

[70]  E. Olson,et al.  Cardiac plasticity. , 2008, The New England journal of medicine.

[71]  Carolyn Y. Ho,et al.  Is Genotype Clinically Useful in Predicting Prognosis in Hypertrophic Cardiomyopathy? Genetics and Clinical Destiny: Improving Care in Hypertrophic Cardiomyopathy Response by Landstrom on P 2440 Genetics of Hcm Controversies in Cardiovascular Medicine , 2022 .

[72]  G. Dorn,et al.  Human phospholamban null results in lethal dilated cardiomyopathy revealing a critical difference between mouse and human. , 2003, The Journal of clinical investigation.

[73]  U. Schotten,et al.  Early subcellular Ca2+ remodelling and increased propensity for Ca2+ alternans in left atrial myocytes from hypertensive rats. , 2015, Cardiovascular research.

[74]  N. Weissman,et al.  Inotropic Stimulation Induces Cardiac Dysfunction in Transgenic Mice Expressing a Troponin T (I79N) Mutation Linked to Familial Hypertrophic Cardiomyopathy* , 2001, The Journal of Biological Chemistry.

[75]  Takeo Tanaami,et al.  Difference in propagation of Ca2+ release in atrial and ventricular myocytes. , 2005, The Japanese journal of physiology.

[76]  M. Horie,et al.  Association of atrial arrhythmia and sinus node dysfunction in patients with catecholaminergic polymorphic ventricular tachycardia. , 2007, Circulation journal : official journal of the Japanese Circulation Society.

[77]  Amy D. Hanna,et al.  Proteins within the intracellular calcium store determine cardiac RyR channel activity and cardiac output , 2012, Clinical and experimental pharmacology & physiology.

[78]  R. Matsuoka,et al.  Mutation of the phospholamban promoter associated with hypertrophic cardiomyopathy. , 2003, Biochemical and biophysical research communications.

[79]  A. Børglum,et al.  α-cardiac actin is a novel disease gene in familial hypertrophic cardiomyopathy , 1999 .

[80]  Alan Garfinkel,et al.  Spatially discordant alternans in cardiac tissue: role of calcium cycling. , 2005, Circulation research.

[81]  M. Iino,et al.  Junctophilins: a novel family of junctional membrane complex proteins. , 2000, Molecular cell.

[82]  Mark A. Magnuson,et al.  Oestrogen protects FKBP12.6 null mice from cardiac hypertrophy , 2002, Nature.

[83]  Leif Hove-Madsen,et al.  Atrial Fibrillation Is Associated With Increased Spontaneous Calcium Release From the Sarcoplasmic Reticulum in Human Atrial Myocytes , 2004, Circulation.

[84]  X. Wehrens,et al.  Targeting ryanodine receptors for anti-arrhythmic therapy , 2011, Acta Pharmacologica Sinica.

[85]  C. Heizmann,et al.  Ca2+ -dependent interaction of S100A1 with the sarcoplasmic reticulum Ca2+ -ATPase2a and phospholamban in the human heart. , 2003, Biochemical and biophysical research communications.

[86]  N. Kaneko,et al.  K201, a multi-channel blocker, inhibits clofilium-induced torsades de pointes and attenuates an increase in repolarization. , 2007, European journal of pharmacology.

[87]  D. Bers,et al.  Protein Kinase A Phosphorylation of the Ryanodine Receptor Does Not Affect Calcium Sparks in Mouse Ventricular Myocytes , 2002, Circulation research.

[88]  P. Kirchhof,et al.  Familial Hypertrophic Cardiomyopathy-Linked Mutant Troponin T Causes Stress-Induced Ventricular Tachycardia and Ca2+-Dependent Action Potential Remodeling , 2003, Circulation research.

[89]  Stephen H. Smith,et al.  Gene-Targeted Mice with the Human Troponin T R141W Mutation Develop Dilated Cardiomyopathy with Calcium Desensitization , 2016, PloS one.

[90]  M. Drazner,et al.  2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2013, Journal of the American College of Cardiology.

[91]  Saumya Das,et al.  Development of dilated cardiomyopathy and impaired calcium homeostasis with cardiac-specific deletion of ESRRβ. , 2017, American journal of physiology. Heart and circulatory physiology.

[92]  S. Priori,et al.  CaV1.2 Calcium Channel Dysfunction Causes a Multisystem Disorder Including Arrhythmia and Autism , 2004, Cell.

[93]  M. Faggioni,et al.  Calsequestrin Mutations and Catecholaminergic Polymorphic Ventricular Tachycardia , 2012, Pediatric Cardiology.

[94]  W. Catterall Correction for Fu et al., Phosphorylation sites required for regulation of cardiac calcium channels in the fight-or-flight response , 2014, Proceedings of the National Academy of Sciences.

[95]  D. Dobrev,et al.  Function and regulation of serine/threonine phosphatases in the healthy and diseased heart. , 2013, Journal of molecular and cellular cardiology.

[96]  E. Schulze-Bahr,et al.  Gain-of-function mutations in the calcium channel CACNA1C (Cav1.2) cause non-syndromic long-QT but not Timothy syndrome. , 2015, Journal of molecular and cellular cardiology.

[97]  D. Zipes Mechanisms of Clinical Arrhythmias , 2003, Pacing and clinical electrophysiology : PACE.

[98]  S. Solomon,et al.  Mapping a gene for familial hypertrophic cardiomyopathy to chromosome 14q1. , 1989, The New England journal of medicine.

[99]  D. Bers Cardiac excitation–contraction coupling , 2002, Nature.

[100]  M. Ackerman,et al.  Is Genotype Clinically Useful in Predicting Prognosis in Hypertrophic Cardiomyopathy? Mutation Type Is Not Clinically Useful in Predicting Prognosis in Hypertrophic Cardiomyopathy Response by Ho on P 2450 Controversies in Cardiovascular Medicine , 2022 .

[101]  D. Bers,et al.  Ca2+/Calmodulin–Dependent Protein Kinase Modulates Cardiac Ryanodine Receptor Phosphorylation and Sarcoplasmic Reticulum Ca2+ Leak in Heart Failure , 2005, Circulation research.

[102]  M. Ackerman,et al.  Dysferlin, Annexin A1, and Mitsugumin 53 Are Upregulated in Muscular Dystrophy and Localize to Longitudinal Tubules of the T-System With Stretch , 2011, Journal of neuropathology and experimental neurology.

[103]  Colleen E. Clancy,et al.  In silico prediction of drug therapy in catecholaminergic polymorphic ventricular tachycardia , 2015, The Journal of physiology.

[104]  D. Sanoudou,et al.  Histidine-rich Ca-binding protein interacts with sarcoplasmic reticulum Ca-ATPase. , 2007, American journal of physiology. Heart and circulatory physiology.

[105]  G. Lip,et al.  EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: definition, characterization, and clinical implication. , 2016, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[106]  S. Ogawa,et al.  Development of Newer Calcium Channel Antagonists , 2009, Drugs.

[107]  M. Keating,et al.  Long QT syndrome associated with syndactyly identified in females. , 1995, The American journal of cardiology.

[108]  X. Wehrens,et al.  Intracellular calcium leak due to FKBP12.6 deficiency in mice facilitates the inducibility of atrial fibrillation. , 2008, Heart rhythm.

[109]  Kirsi Penttinen,et al.  Antiarrhythmic Effects of Dantrolene in Patients with Catecholaminergic Polymorphic Ventricular Tachycardia and Replication of the Responses Using iPSC Models , 2015, PloS one.

[110]  S. Ommen,et al.  Molecular and functional characterization of novel hypertrophic cardiomyopathy susceptibility mutations in TNNC1-encoded troponin C. , 2007, Journal of molecular and cellular cardiology.

[111]  J. Seidman,et al.  Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy. , 1992, The New England journal of medicine.

[112]  Biykem Bozkurt,et al.  2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. , 2013, Circulation.

[113]  M. Keating,et al.  MiRP1 Forms IKr Potassium Channels with HERG and Is Associated with Cardiac Arrhythmia , 1999, Cell.

[114]  C. Ward,et al.  Leaky Ca2+ release channel/ryanodine receptor 2 causes seizures and sudden cardiac death in mice. , 2008, The Journal of clinical investigation.

[115]  M. Komajda,et al.  Familial hypertrophic cardiomyopathy: the same mutation, different prognosis. Comparison of two families with a long follow-up. , 2003, Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology.

[116]  B. Knollmann,et al.  Triple mode of action of flecainide in catecholaminergic polymorphic ventricular tachycardia. , 2013, Cardiovascular research.

[117]  M. Rosen,et al.  Defective Cardiac Ryanodine Receptor Regulation During Atrial Fibrillation , 2005, Circulation.

[118]  A. Leenhardt,et al.  Absence of triadin, a protein of the calcium release complex, is responsible for cardiac arrhythmia with sudden death in human , 2012, Human molecular genetics.

[119]  Wenjun Xie,et al.  Calcium Leak Through Ryanodine Receptors Leads to Atrial Fibrillation in 3 Mouse Models of Catecholaminergic Polymorphic Ventricular Tachycardia , 2012, Circulation research.

[120]  A. J. Williams,et al.  Triple mode of action of flecainide in catecholaminergic polymorphic ventricular tachycardia: reply. , 2013, Cardiovascular research.

[121]  K. Ueda,et al.  A novel SCN5A mutation associated with idiopathic ventricular fibrillation without typical ECG findings of Brugada syndrome , 2000, FEBS letters.

[122]  Laura Iop,et al.  Dantrolene rescues arrhythmogenic RYR2 defect in a patient-specific stem cell model of catecholaminergic polymorphic ventricular tachycardia , 2012, EMBO molecular medicine.

[123]  X. Wehrens,et al.  Junctophilin-2 at the intersection of arrhythmia and pathologic cardiac remodeling. , 2016, Heart Rhythm.

[124]  James O. Mudd,et al.  An abnormal Ca(2+) response in mutant sarcomere protein-mediated familial hypertrophic cardiomyopathy. , 2000, The Journal of clinical investigation.

[125]  J. Fauré,et al.  Triadin: what possible function 20 years later? , 2009, The Journal of physiology.

[126]  MasafumiYano,et al.  Altered Stoichiometry of FKBP12.6 Versus Ryanodine Receptor as a Cause of Abnormal Ca2+ Leak Through Ryanodine Receptor in Heart Failure , 2000 .

[127]  G. Breithardt,et al.  Genetic basis and molecular mechanism for idiopathic ventricular fibrillation , 1998, Nature.

[128]  S. Ommen,et al.  Genetics of hypertrophic cardiomyopathy: one, two, or more diseases? , 2007, Current opinion in cardiology.

[129]  S. Priori,et al.  FKBP12.6 Deficiency and Defective Calcium Release Channel (Ryanodine Receptor) Function Linked to Exercise-Induced Sudden Cardiac Death , 2003, Cell.

[130]  A. Auricchio,et al.  True idiopathic ventricular fibrillation in out‐of‐hospital cardiac arrest survivors in the Swiss Canton Ticino: prevalence, clinical features, and long‐term follow‐up , 2016, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[131]  Na Li,et al.  Cellular and Molecular Mechanisms of Atrial Arrhythmogenesis in Patients With Paroxysmal Atrial Fibrillation , 2014, Circulation.

[132]  T. Herron,et al.  Altered myocyte contractility and calcium homeostasis in alpha-myosin heavy chain point mutations linked to familial dilated cardiomyopathy. , 2017, Archives of biochemistry and biophysics.

[133]  Frank B Sachse,et al.  Severe arrhythmia disorder caused by cardiac L-type calcium channel mutations. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[134]  J. Deharo,et al.  Prevalence and significance of rare RYR2 variants in arrhythmogenic right ventricular cardiomyopathy/dysplasia: results of a systematic screening. , 2014, Heart rhythm.

[135]  S. Priori,et al.  Mutations in the Cardiac Ryanodine Receptor Gene (hRyR2) Underlie Catecholaminergic Polymorphic Ventricular Tachycardia , 2001, Circulation.

[136]  Rachael,et al.  Myofilament protein gene mutation screening and outcome of patients with hypertrophic cardiomyopathy. , 2008, Mayo Clinic proceedings.

[137]  José Jalife,et al.  Arrhythmogenic Mechanisms in a Mouse Model of Catecholaminergic Polymorphic Ventricular Tachycardia , 2007, Circulation research.

[138]  Shi-Xian Deng,et al.  Protection from Cardiac Arrhythmia Through Ryanodine Receptor-Stabilizing Protein Calstabin2 , 2004, Science.

[139]  M. Matsuzaki,et al.  Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathy , 1997, Nature Genetics.

[140]  S Ringer,et al.  A further Contribution regarding the influence of the different Constituents of the Blood on the Contraction of the Heart , 1883, The Journal of physiology.

[141]  R. Hershberger,et al.  A novel human R25C-phospholamban mutation is associated with super-inhibition of calcium cycling and ventricular arrhythmia. , 2015, Cardiovascular research.

[142]  S. Priori,et al.  Abnormal Calcium Signaling and Sudden Cardiac Death Associated With Mutation of Calsequestrin , 2004, Circulation research.

[143]  S. Fleischer,et al.  The nature of the modulation of Ca2+ transport as studied by reconstitution of cardiac sarcoplasmic reticulum. , 1986, The Journal of biological chemistry.

[144]  C. Napolitano,et al.  Phenotypical Manifestations of Mutations in the Genes Encoding Subunits of the Cardiac Voltage–Dependent L-Type Calcium Channel , 2011, Circulation research.

[145]  Mark E. Anderson,et al.  Calmodulin-dependent protein kinase II: linking heart failure and arrhythmias. , 2012, Circulation research.

[146]  Thomas Meitinger,et al.  Calmodulin Mutations Associated With Recurrent Cardiac Arrest in Infants , 2013, Circulation.

[147]  X. Wehrens,et al.  Defects in Ankyrin-Based Membrane Protein Targeting Pathways Underlie Atrial Fibrillation , 2011, Circulation.

[148]  A. J. Williams,et al.  Physiological consequences of the P2328S mutation in the ryanodine receptor (RyR2) gene in genetically modified murine hearts , 2008, Acta physiologica.

[149]  E. Homsher,et al.  Regulation of contraction in striated muscle. , 2000, Physiological reviews.

[150]  M. Yano,et al.  A new cardioprotective agent, JTV519, improves defective channel gating of ryanodine receptor in heart failure. , 2003, American journal of physiology. Heart and circulatory physiology.

[151]  A. Scholten,et al.  Alterations in the interactome of serine/threonine protein phosphatase type-1 in atrial fibrillation patients. , 2015, Journal of the American College of Cardiology.

[152]  C. D. dos Remedios,et al.  Ryanodine receptor modification and regulation by intracellular Ca2+ and Mg2+ in healthy and failing human hearts. , 2017, Journal of molecular and cellular cardiology.

[153]  X. Wehrens,et al.  Ryanodine receptor phosphorylation, calcium/calmodulin-dependent protein kinase II, and life-threatening ventricular arrhythmias. , 2011, Trends in cardiovascular medicine.

[154]  Min Zhang,et al.  Identification of MicroRNA‐mRNA Dysregulations in Paroxysmal Atrial Fibrillation , 2015, International journal of cardiology.

[155]  M. Ackerman,et al.  Beyond the cardiac myofilament: hypertrophic cardiomyopathy- associated mutations in genes that encode calcium-handling proteins. , 2012, Current molecular medicine.

[156]  A. Børglum,et al.  Alpha-cardiac actin is a novel disease gene in familial hypertrophic cardiomyopathy. , 1999, The Journal of clinical investigation.

[157]  G. Meissner,et al.  Molecular Basis of Calmodulin Binding to Cardiac Muscle Ca2+ Release Channel (Ryanodine Receptor)* , 2003, Journal of Biological Chemistry.

[158]  K. Chien,et al.  Reversing advanced heart failure by targeting Ca2+ cycling. , 2008, Annual review of medicine.

[159]  R. Tsien,et al.  A novel type of cardiac calcium channel in ventricular cells , 1985, Nature.

[160]  J. Seidman,et al.  Calsequestrin 2 (CASQ2) mutations increase expression of calreticulin and ryanodine receptors, causing catecholaminergic polymorphic ventricular tachycardia. , 2007, The Journal of clinical investigation.

[161]  S. Viskin,et al.  Calcium channel blockers and beta-blockers versus beta-blockers alone for preventing exercise-induced arrhythmias in catecholaminergic polymorphic ventricular tachycardia. , 2007, Heart rhythm.

[162]  M. Ackerman,et al.  Novel long QT syndrome-associated missense mutation, L762F, in CACNA1C-encoded L-type calcium channel imparts a slower inactivation tau and increased sustained and window current. , 2016, International journal of cardiology.

[163]  Ofer Binah,et al.  Cardiomyocytes generated from CPVTD307H patients are arrhythmogenic in response to β-adrenergic stimulation , 2012, Journal of cellular and molecular medicine.

[164]  T. Wieland,et al.  Enhanced Sarcoplasmic Reticulum Ca2+ Leak and Increased Na+-Ca2+ Exchanger Function Underlie Delayed Afterdepolarizations in Patients With Chronic Atrial Fibrillation , 2012, Circulation.

[165]  Silvia G Priori,et al.  Inherited dysfunction of sarcoplasmic reticulum Ca2+ handling and arrhythmogenesis. , 2011, Circulation research.

[166]  X. Wehrens,et al.  Animal models of arrhythmogenic cardiomyopathy , 2009, Disease Models & Mechanisms.

[167]  Stanley Nattel,et al.  Calcium-Handling Abnormalities Underlying Atrial Arrhythmogenesis and Contractile Dysfunction in Dogs With Congestive Heart Failure , 2008, Circulation. Arrhythmia and electrophysiology.

[168]  X. Wehrens,et al.  Mechanisms of human arrhythmia syndromes: abnormal cardiac macromolecular interactions. , 2007, Physiology.

[169]  David W Piston,et al.  Flecainide inhibits arrhythmogenic Ca2+ waves by open state block of ryanodine receptor Ca2+ release channels and reduction of Ca2+ spark mass. , 2010, Journal of molecular and cellular cardiology.

[170]  L. Eckardt,et al.  Triggered activity in atrial myocytes is influenced by Na+/Ca2+ exchanger activity in genetically altered mice. , 2016, Journal of molecular and cellular cardiology.

[171]  D. Burkhoff,et al.  PKA Phosphorylation Dissociates FKBP12.6 from the Calcium Release Channel (Ryanodine Receptor) Defective Regulation in Failing Hearts , 2000, Cell.

[172]  J. Gummert,et al.  Antiarrhythmic effects of dantrolene in human diseased cardiomyocytes. , 2017, Heart rhythm.

[173]  Daniel Levy,et al.  Long-term trends in the incidence of and survival with heart failure. , 2002, The New England journal of medicine.

[174]  M. Morad,et al.  Ca2+ signaling in human induced pluripotent stem cell-derived cardiomyocytes (iPS-CM) from normal and catecholaminergic polymorphic ventricular tachycardia (CPVT)-afflicted subjects. , 2013, Cell calcium.

[175]  A. Noma,et al.  EAD and DAD mechanisms analyzed by developing a new human ventricular cell model. , 2014, Progress in biophysics and molecular biology.

[176]  KerstinDudas,et al.  Trends in Out-of-Hospital Deaths Due to Coronary Heart Disease in Sweden (1991 to 2006) , 2011 .

[177]  D. Roden,et al.  Flecainide prevents catecholaminergic polymorphic ventricular tachycardia in mice and humans , 2009, Nature Medicine.

[178]  D. Dobrev,et al.  Calcium Handling Abnormalities as a Target for Atrial Fibrillation Therapeutics: How Close to Clinical Implementation? , 2015, Journal of cardiovascular pharmacology.

[179]  D. Roden,et al.  Casq2 deletion causes sarcoplasmic reticulum volume increase, premature Ca2+ release, and catecholaminergic polymorphic ventricular tachycardia. , 2006, The Journal of clinical investigation.

[180]  A. J. Williams,et al.  Flecainide reduces Ca2+ spark and wave frequency via inhibition of the sarcolemmal sodium current , 2013, Cardiovascular research.

[181]  Andrew D McCulloch,et al.  Nonequilibrium Reactivation of Na+ Current Drives Early Afterdepolarizations in Mouse Ventricle , 2014, Circulation. Arrhythmia and electrophysiology.

[182]  J. van der Velden,et al.  Alterations in contractile protein composition and function in human atrial dilatation and atrial fibrillation. , 2006, Journal of molecular and cellular cardiology.

[183]  Henggui Zhang,et al.  Pro-arrhythmogenic effects of CACNA1C G1911R mutation in human ventricular tachycardia: insights from cardiac multi-scale models , 2016, Scientific Reports.

[184]  Godfrey L. Smith,et al.  Chronic myocardial infarction promotes atrial action potential alternans, afterdepolarizations, and fibrillation , 2013, Cardiovascular research.

[185]  Gaetano Santulli,et al.  Imaging atrial arrhythmic intracellular calcium in intact heart. , 2013, Journal of molecular and cellular cardiology.

[186]  D. Lancet,et al.  A missense mutation in a highly conserved region of CASQ2 is associated with autosomal recessive catecholamine-induced polymorphic ventricular tachycardia in Bedouin families from Israel. , 2001, American journal of human genetics.

[187]  S. Priori,et al.  Bidirectional Ventricular Tachycardia and Fibrillation Elicited in a Knock-In Mouse Model Carrier of a Mutation in the Cardiac Ryanodine Receptor , 2005, Circulation research.

[188]  Michael Eldar,et al.  Functional abnormalities in iPSC-derived cardiomyocytes generated from CPVT1 and CPVT2 patients carrying ryanodine or calsequestrin mutations , 2015, Journal of cellular and molecular medicine.

[189]  D. Driscoll,et al.  Myosin Light Chain Mutation Causes Autosomal Recessive Cardiomyopathy With Mid-Cavitary Hypertrophy and Restrictive Physiology , 2002, Circulation.

[190]  G. Salama,et al.  Treatment of catecholaminergic polymorphic ventricular tachycardia in mice using novel RyR2-modifying drugs. , 2017, International journal of cardiology.

[191]  Stephan E. Lehnart,et al.  Ca2+/Calmodulin-Dependent Protein Kinase II Phosphorylation Regulates the Cardiac Ryanodine Receptor , 2004, Circulation research.

[192]  H. Mabuchi,et al.  Clinical features of hypertrophic cardiomyopathy caused by a Lys183 deletion mutation in the cardiac troponin I gene. , 2000, Circulation.

[193]  G. Dorn,et al.  A mutation in the human phospholamban gene, deleting arginine 14, results in lethal, hereditary cardiomyopathy , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[194]  L. Monserrat,et al.  Mutational screening of phospholamban gene in hypertrophic and idiopathic dilated cardiomyopathy and functional study of the PLN –42 C>G mutation , 2007, European journal of heart failure.

[195]  D. Kastner,et al.  Autosomal Recessive Catecholamine- or Exercise-Induced Polymorphic Ventricular Tachycardia: Clinical Features and Assignment of the Disease Gene to Chromosome 1p13-21 , 2001, Circulation.

[196]  J. Benitah,et al.  L-type Ca(2+) current in ventricular cardiomyocytes. , 2010, Journal of molecular and cellular cardiology.

[197]  Katriina Aalto-Setälä,et al.  Cell Model of Catecholaminergic Polymorphic Ventricular Tachycardia Reveals Early and Delayed Afterdepolarizations , 2012, PloS one.

[198]  J. Neilson,et al.  Loss of MicroRNA-106b-25 Cluster Promotes Atrial Fibrillation by Enhancing Ryanodine Receptor Type-2 Expression and Calcium Release , 2014, Circulation. Arrhythmia and electrophysiology.

[199]  D. T. Yue,et al.  Calmodulin bifurcates the local Ca2+ signal that modulates P/Q-type Ca2+ channels , 2001, Nature.

[200]  R. Reithmeier,et al.  Characterization of cardiac calsequestrin. , 1987, Biochemistry.

[201]  Richard T. Lee,et al.  Heart failure with preserved ejection fraction: molecular pathways of the aging myocardium. , 2014, Circulation research.

[202]  Dobromir Dobrev,et al.  Serine/Threonine Phosphatases in Atrial Fibrillation. , 2017, Journal of molecular and cellular cardiology.

[203]  M. Ackerman,et al.  CALM3 mutation associated with long QT syndrome. , 2015, Heart rhythm.

[204]  D. Terentyev,et al.  Sarcoplasmic reticulum Ca²⁺ release is both necessary and sufficient for SK channel activation in ventricular myocytes. , 2014, American journal of physiology. Heart and circulatory physiology.

[205]  R. Shephard Sudden Deaths in Young Competitive Athletes: Analysis of 1866 Deaths in the United States, 1980–2006 , 2010 .

[206]  Brian J. Stevenson,et al.  TECRL, a new life‐threatening inherited arrhythmia gene associated with overlapping clinical features of both LQTS and CPVT , 2016, EMBO molecular medicine.

[207]  Michael J Ackerman,et al.  Novel Timothy syndrome mutation leading to increase in CACNA1C window current. , 2015, Heart rhythm.

[208]  L. Fananapazir,et al.  Genotype-Phenotpe Correlations in Hypertrophic Cardiomyopathy Insights Provided by Comparisons of Kindreds With Distinct and Identical j3-Myosin Heavy Chain Gene Mutations , 2005 .

[209]  R. Hajjar,et al.  Modulation of Cardiac Contractility by the Phopholamban/SERCA2a Regulatome , 2012, Circulation research.

[210]  A. Wilde,et al.  A Novel Early Onset Lethal Form of Catecholaminergic Polymorphic Ventricular Tachycardia Maps to Chromosome 7p14‐p22 , 2007, Journal of cardiovascular electrophysiology.

[211]  M. Lisanti,et al.  Caveolae and caveolin-3 in muscular dystrophy. , 2001, Trends in molecular medicine.

[212]  Stephan E Lehnart,et al.  Intracellular calcium release and cardiac disease. , 2005, Annual review of physiology.

[213]  G. Ellis‐Davies,et al.  Rapid adaptation of cardiac ryanodine receptors: modulation by Mg2+ and phosphorylation. , 1995, Science.

[214]  M. Ferenczi,et al.  The Dilated Cardiomyopathy-Causing Mutation ACTC E361G in Cardiac Muscle Myofibrils Specifically Abolishes Modulation of Ca2+ Regulation by Phosphorylation of Troponin I , 2014, Biophysical journal.

[215]  Sanjiv M Narayan,et al.  The role of action potential alternans in the initiation of atrial fibrillation in humans: a review and future directions. , 2012, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[216]  C. Luo,et al.  Electrophysiological mechanisms of ventricular arrhythmias in relation to Andersen-Tawil syndrome under conditions of reduced IK1: a simulation study. , 2006, American journal of physiology. Heart and circulatory physiology.

[217]  H. Duff,et al.  Carvedilol and its new analogs suppress arrhythmogenic store overload–induced Ca2+ release , 2011, Nature Medicine.

[218]  Carlo Napolitano,et al.  Clinical and Molecular Characterization of Patients With Catecholaminergic Polymorphic Ventricular Tachycardia , 2002, Circulation.

[219]  J. Arthur,et al.  Genetic screening of calcium regulation genes in familial hypertrophic cardiomyopathy. , 2007, Journal of molecular and cellular cardiology.

[220]  P. Coumel,et al.  Catecholaminergic polymorphic ventricular tachycardia in children. A 7-year follow-up of 21 patients. , 1995, Circulation.

[221]  U. Schotten,et al.  Calmodulin kinase II-mediated sarcoplasmic reticulum Ca2+ leak promotes atrial fibrillation in mice. , 2009, The Journal of clinical investigation.

[222]  S. Priori,et al.  Purkinje cell calcium dysregulation is the cellular mechanism that underlies catecholaminergic polymorphic ventricular tachycardia. , 2010, Heart rhythm.

[223]  S. Fleischer,et al.  Selective Binding of FKBP12.6 by the Cardiac Ryanodine Receptor* , 1996, The Journal of Biological Chemistry.

[224]  Kuai Yu,et al.  Molecular Mechanism for Divergent Regulation of Cav1.2 Ca2+ Channels by Calmodulin and Ca2+-binding Protein-1* , 2005, Journal of Biological Chemistry.

[225]  D. Tester,et al.  Compendium of cardiac channel mutations in 541 consecutive unrelated patients referred for long QT syndrome genetic testing. , 2005, Heart rhythm.

[226]  R. Lazzara,et al.  Role of Na+:Ca2+ Exchange Current in Cs+‐Induced Early Afterdepolarizations in Purkinje Fibers , 1994, Journal of cardiovascular electrophysiology.

[227]  A. Grace,et al.  Atrial arrhythmia, triggering events and conduction abnormalities in isolated murine RyR2‐P2328S hearts , 2013, Acta physiologica.

[228]  S. Nattel,et al.  The value of basic research insights into atrial fibrillation mechanisms as a guide to therapeutic innovation: a critical analysis. , 2016, Cardiovascular research.

[229]  S. Ommen,et al.  Mutations in JPH2-encoded junctophilin-2 associated with hypertrophic cardiomyopathy in humans. , 2007, Journal of molecular and cellular cardiology.

[230]  D. Bers,et al.  Influence of a constitutive increase in myofilament Ca(2+)-sensitivity on Ca(2+)-fluxes and contraction of mouse heart ventricular myocytes. , 2014, Archives of biochemistry and biophysics.

[231]  J. Seidman,et al.  Mutations in the genes for cardiac troponin T and alpha-tropomyosin in hypertrophic cardiomyopathy. , 1995, The New England journal of medicine.

[232]  K. Sipido,et al.  Na/Ca Exchange and Cardiac Ventricular Arrhythmias , 2007, Annals of the New York Academy of Sciences.

[233]  P. Kirchhof,et al.  Heart-directed Expression of a Human Cardiac Isoform of cAMP-Response Element Modulator in Transgenic Mice* , 2005, Journal of Biological Chemistry.

[234]  J. H. Collins,et al.  Sequence analysis of phospholamban. Identification of phosphorylation sites and two major structural domains. , 1986, The Journal of biological chemistry.

[235]  David T. Yue,et al.  Mechanism of Local and Global Ca2+ Sensing by Calmodulin in Complex with a Ca2+ Channel , 2008, Cell.

[236]  T. Kamp,et al.  Caveolae, ion channels and cardiac arrhythmias. , 2008, Progress in biophysics and molecular biology.

[237]  Michael J Ackerman,et al.  Disrupted Junctional Membrane Complexes and Hyperactive Ryanodine Receptors After Acute Junctophilin Knockdown in Mice , 2011, Circulation.

[238]  E. Lakatta,et al.  The immunophilin FK506‐binding protein modulates Ca2+ release channel closure in rat heart. , 1997, The Journal of physiology.

[239]  A. Gomes,et al.  Mutations in Troponin that cause HCM, DCM AND RCM: what can we learn about thin filament function? , 2010, Journal of molecular and cellular cardiology.

[240]  Lei Guo,et al.  Calreticulin in the heart , 2004, Molecular and Cellular Biochemistry.

[241]  W. Chazin,et al.  Arrhythmogenic Calmodulin Mutations Affect the Activation and Termination of Cardiac Ryanodine Receptor-mediated Ca2+ Release* , 2015, The Journal of Biological Chemistry.

[242]  A. Terzic,et al.  Calreticulin secures calcium-dependent nuclear pore competency required for cardiogenesis. , 2016, Journal of molecular and cellular cardiology.

[243]  D. Bers,et al.  Role of sodium and calcium dysregulation in tachyarrhythmias in sudden cardiac death. , 2015, Circulation research.

[244]  H. Fozzard Cardiac sodium and calcium channels: a history of excitatory currents. , 2002, Cardiovascular research.

[245]  J. Seidman,et al.  A molecular basis for familial hypertrophic cardiomyopathy: A β cardiac myosin heavy chain gene missense mutation , 1990, Cell.

[246]  J. Svendsen,et al.  Integration of 60,000 exomes and ACMG guidelines question the role of Catecholaminergic Polymorphic Ventricular Tachycardia‐associated variants , 2017, Clinical genetics.

[247]  J. Jalife,et al.  Ion channel macromolecular complexes in cardiomyocytes: roles in sudden cardiac death. , 2015, Circulation research.

[248]  H. Katus,et al.  Mechanisms of disease: hypertrophic cardiomyopathy , 2012, Nature Reviews Cardiology.

[249]  D. Dobrev Unique cardiomyocyte ultrastructure in atria: Role of T tubules in subcellular Ca2+ signaling and atrial arrhythmogenesis. , 2017, Heart rhythm.

[250]  B. Maron Hypertrophic cardiomyopathy: a systematic review. , 2002, JAMA.

[251]  K. Campbell,et al.  Biochemical characterization of ultrastructural localization of a major junctional sarcoplasmic reticulum glycoprotein (triadin). , 1993, The Journal of biological chemistry.

[252]  Christopher N. Johnson,et al.  Spectrum and Prevalence of CALM1-, CALM2-, and CALM3-Encoded Calmodulin Variants in Long QT Syndrome and Functional Characterization of a Novel Long QT Syndrome–Associated Calmodulin Missense Variant, E141G , 2016, Circulation. Cardiovascular genetics.

[253]  D. V. Van Wagoner,et al.  Adenosine-Induced Atrial Fibrillation: Localized Reentrant Drivers in Lateral Right Atria due to Heterogeneous Expression of Adenosine A1 Receptors and GIRK4 Subunits in the Human Heart. , 2016, Circulation.

[254]  S. Ommen,et al.  PLN-encoded phospholamban mutation in a large cohort of hypertrophic cardiomyopathy cases: summary of the literature and implications for genetic testing. , 2011, American heart journal.

[255]  H. Theile,et al.  [The heart-hand syndrome. A new variant of disorders of heart conduction and syndactylia including osseous changes in hands and feet]. , 1992, Kinderarztliche Praxis.

[256]  Heping Cheng,et al.  Calcium sparks. , 2008, Physiological reviews.

[257]  S. Prasad,et al.  Genetics and genomics of dilated cardiomyopathy and systolic heart failure , 2017, Genome Medicine.

[258]  Michael Fill,et al.  Mechanism of calsequestrin regulation of single cardiac ryanodine receptor in normal and pathological conditions , 2013, The Journal of general physiology.

[259]  S. Houser Does protein kinase a-mediated phosphorylation of the cardiac ryanodine receptor play any role in adrenergic regulation of calcium handling in health and disease? , 2010, Circulation research.

[260]  B. J. Gersh Explaining the Decrease in U.S. Deaths from Coronary Disease, 1980–2000 , 2008 .

[261]  Manuel F. Navedo,et al.  Graded Ca2+/calmodulin-dependent coupling of voltage-gated CaV1.2 channels , 2015, eLife.

[262]  X. Wehrens,et al.  The junctophilin family of proteins: from bench to bedside. , 2014, Trends in molecular medicine.

[263]  D. Dobrev,et al.  Transverse tubules are a common feature in large mammalian atrial myocytes including human. , 2011, American journal of physiology. Heart and circulatory physiology.

[264]  M. Sanguinetti,et al.  Mutations in the hminK gene cause long QT syndrome and suppress lKs function , 1997, Nature Genetics.

[265]  S. Nattel,et al.  Ryanodine Receptor–Mediated Calcium Leak Drives Progressive Development of an Atrial Fibrillation Substrate in a Transgenic Mouse Model , 2014, Circulation.

[266]  A. Terzic,et al.  Pharmacological Modulation of Calcium Homeostasis in Familial Dilated Cardiomyopathy: An In Vitro Analysis From an RBM20 Patient‐Derived iPSC Model , 2016, Clinical and translational science.

[267]  K. Brown,et al.  Mutations of the Cardiac Ryanodine Receptor (RyR2) Gene in Familial Polymorphic Ventricular Tachycardia , 2001, Circulation.

[268]  T. Kondo,et al.  Overexpression of calreticulin sensitizes SERCA2a to oxidative stress. , 2005, Biochemical and biophysical research communications.

[269]  Steven R Houser,et al.  Role of RyR2 Phosphorylation in Heart Failure and Arrhythmias: Protein Kinase A–Mediated Hyperphosphorylation of the Ryanodine Receptor at Serine 2808 Does Not Alter Cardiac Contractility or Cause Heart Failure and Arrhythmias , 2014, Circulation research.

[270]  Rosy Joshi-Mukherjee,et al.  Calmodulin mutations associated with long QT syndrome prevent inactivation of cardiac L-type Ca(2+) currents and promote proarrhythmic behavior in ventricular myocytes. , 2014, Journal of molecular and cellular cardiology.

[271]  M. Yano,et al.  Altered Stoichiometry of FKBP12.6 Versus Ryanodine Receptor as a Cause of Abnormal Ca2 Leak Through Ryanodine Receptor in Heart Failure , 2000, Circulation.

[272]  Michael J. Ackerman,et al.  Identification and Functional Characterization of a Novel CACNA1C-Mediated Cardiac Disorder Characterized by Prolonged QT Intervals With Hypertrophic Cardiomyopathy, Congenital Heart Defects, and Sudden Cardiac Death , 2015, Circulation. Arrhythmia and electrophysiology.

[273]  Christine E. Seidman,et al.  α-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: A disease of the sarcomere , 1994, Cell.

[274]  S. Priori,et al.  Inherited calcium channelopathies in the pathophysiology of arrhythmias , 2012, Nature Reviews Cardiology.

[275]  George S. B. Williams,et al.  Axial tubule junctions control rapid calcium signaling in atria. , 2016, The Journal of clinical investigation.

[276]  U. Schotten,et al.  Transient Receptor Potential Canonical-3 Channel–Dependent Fibroblast Regulation in Atrial Fibrillation , 2012, Circulation.

[277]  A. Fleckenstein History of Calcium Antagonists , 1983, Circulation research.

[278]  Niels Voigt,et al.  Calcium dysregulation in atrial fibrillation: the role of CaMKII , 2014, Front. Pharmacol..

[279]  L. Blatter,et al.  The mechanisms of calcium cycling and action potential dynamics in cardiac alternans. , 2015, Circulation research.

[280]  M. Ackerman,et al.  Junctophilin-2 Expression Silencing Causes Cardiocyte Hypertrophy and Abnormal Intracellular Calcium-Handling , 2011, Circulation. Heart failure.

[281]  M Miragoli,et al.  CaMKII inhibition rectifies arrhythmic phenotype in a patient-specific model of catecholaminergic polymorphic ventricular tachycardia , 2013, Cell Death and Disease.

[282]  M. Ackerman,et al.  Mutation E169K in junctophilin-2 causes atrial fibrillation due to impaired RyR2 stabilization. , 2013, Journal of the American College of Cardiology.

[283]  W. Catterall,et al.  Purification of the calcium antagonist receptor of the voltage-sensitive calcium channel from skeletal muscle transverse tubules. , 1984, Biochemistry.

[284]  Michael J Ackerman,et al.  Distinguishing Hypertrophic Cardiomyopathy-Associated Mutations from Background Genetic Noise , 2014, Journal of Cardiovascular Translational Research.

[285]  J. Cinca,et al.  Prevention of adenosine A2A receptor activation diminishes beat-to-beat alternation in human atrial myocytes , 2015, Basic Research in Cardiology.

[286]  Riccardo Olcese,et al.  Enhanced Late Na and Ca Currents as Effective Antiarrhythmic Drug Targets , 2017, Front. Pharmacol..

[287]  G. Hasenfuss,et al.  CaMKII-Dependent Diastolic SR Ca2+ Leak and Elevated Diastolic Ca2+ Levels in Right Atrial Myocardium of Patients With Atrial Fibrillation , 2010, Circulation research.

[288]  M. Nishi,et al.  Characterization of human junctophilin subtype genes. , 2000, Biochemical and biophysical research communications.

[289]  Y. Ikeda,et al.  Toward biologically targeted therapy of calcium cycling defects in heart failure. , 2008, Physiology.

[290]  P B Corr,et al.  Mechanisms underlying early and delayed afterdepolarizations induced by catecholamines. , 1990, The American journal of physiology.

[291]  Michael A. Burke,et al.  Mutation analysis of the phospholamban gene in 315 South Africans with dilated, hypertrophic, peripartum and arrhythmogenic right ventricular cardiomyopathies , 2016, Scientific Reports.

[292]  A. Zima,et al.  Inositol‐1,4,5‐trisphosphate‐dependent Ca2+ signalling in cat atrial excitation–contraction coupling and arrhythmias , 2004, The Journal of physiology.

[293]  Hong Liu,et al.  Sodium-calcium exchange initiated by the Ca2+ transient: an arrhythmia trigger within pulmonary veins. , 2006, Journal of the American College of Cardiology.

[294]  A. J. Williams,et al.  Ryanodine receptor mutations in arrhythmia: The continuing mystery of channel dysfunction , 2010, FEBS letters.

[295]  T. Ogura,et al.  Inhibitory effects of JTV‐519, a novel cardioprotective drug, on potassium currents and experimental atrial fibrillation in guinea‐pig hearts , 2000, British journal of pharmacology.

[296]  D. Stephan,et al.  Identification of mutations in the cardiac ryanodine receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2). , 2001, Human molecular genetics.

[297]  X. Wehrens,et al.  Emerging roles of junctophilin-2 in the heart and implications for cardiac diseases. , 2014, Cardiovascular research.

[298]  S. Marx,et al.  Phosphorylation-Dependent Regulation of Ryanodine Receptors , 2001, The Journal of cell biology.

[299]  Stanley Nattel,et al.  The clinical profile and pathophysiology of atrial fibrillation: relationships among clinical features, epidemiology, and mechanisms. , 2014, Circulation research.

[300]  R. Hauer,et al.  Distinguishing arrhythmogenic right ventricular cardiomyopathy/dysplasia-associated mutations from background genetic noise. , 2011, Journal of the American College of Cardiology.

[301]  Niels Voigt,et al.  Cellular and Molecular Electrophysiology of Atrial Fibrillation Initiation, Maintenance, and Progression , 2014, Circulation research.

[302]  Á. Zarain-Herzberg,et al.  Sarcoplasmic reticulum calsequestrins: Structural and functional properties , 1994, Molecular and Cellular Biochemistry.

[303]  Stefan Wagner,et al.  Altered Na(+) currents in atrial fibrillation effects of ranolazine on arrhythmias and contractility in human atrial myocardium. , 2010, Journal of the American College of Cardiology.